Keywords

• Gemcitabine china supplier
• GEMCITABINE HCL USP
• NSC 613327

Quick Details

• ProName: Gemcitabine china manufacture
• CasNo: 95058-81-4
• Molecular Formula: C9H11F2N3O4
• Appearance: White powder
• Application: API
• DeliveryTime: Depend on the quantity client want
• PackAge: According to client's requirements
• Port: SHANGHAI,CHINA
• ProductionCapacity: 10 Metric Ton/Month
• Purity: 99.0%
• Storage: Keep under the shady and cool place an...
• Transportation: By sea/by air/by express
• LimitNum: 1 Kilogram

Superiority

Hangzhou ZeErRui Chemical Co., Ltd. is a leading company that is focused on developing and producing high-quality flavor ingredients used for foods, pharmaceutic, cosmetics, and daily-use goods. Our goal is to produce flavor ingredients through sciences and further to provide our flavor ingredients to products that can delight human life quality.

ZER Chem has capacity to supply more than 200 high-quality flavor ingredients to our customers. Our R&D team works tirelessly and innovatively to develop and customize flavor ingredients to satisfy the needs of our customers. We look forward to collaborating with our customers to bring the best flavor ingredients to the world.

Details

Product name:Gemcitabine

Synonyms:2'-Deoxy-2',2'-difluoro-D-cytidine;2',2'-Difluorodeoxycytidine;Cytidine, 2'-deoxy-2',2'-difluoro-

CAS No:95058-81-4

Molecular formula:C9H11F2N3O4

Molecular Weight:263.2

Appearance:white powders

Specific rotation 365+425.36°;D+71.51°

Melting point 168.64° C

Boiling point 482.7 ± 55.0 ° C(Predicted)

Density 1.84 ± 0.1g/cm³(Predicted)

Acidity coefficient (PKA) 11.65 ± 0.70(Predicted)

Gemcitabine is an antineoplastic drug, similar to pyrimidine, a new type of two fluoronucleoside antimetabolism, which can be combined with cisplatin in the treatment of non-small cell lung cancer, and can also treat advanced or metastatic pancreatic cancer. Gemcitabine is also a kind of bone marrow inhibitor, so blood cell count should be checked during the medication (especially before each intravenous infusion).